Literature DB >> 5686170

Bretylium tosylate for suppression of ventricular fibrillation after experimental myocardial infarction.

M B Bacaner, D Schrienemachers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5686170     DOI： 10.1038/220494a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  3 in total

1.  Potassium channel blockade: A mechanism for suppressing ventricular fibrillation.

Authors:  M B Bacaner; J R Clay; A Shrier; R M Brochu
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

2.  Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.

Authors:  J L Anderson; D C Harrison; P J Meffin; R A Winkle
Journal:  Drugs       Date:  1978-04       Impact factor: 9.546

3.  Preventing ventricular fibrillation by flattening cardiac restitution.

Authors:  A Garfinkel; Y H Kim; O Voroshilovsky; Z Qu; J R Kil; M H Lee; H S Karagueuzian; J N Weiss; P S Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.